Besides setting up a comprehensive, high-quality databank for cancer registration, the Belgian Cancer Registry (BCR) plays an important supportive role in the organisation and quality evaluation of regional population screening for breast, colorectal and cervical cancer.
Belgian pathological anatomy/clinical biology/haematology laboratories are required by law to register the results of breast, cervical and colorectal samples according to specifically established guidelines. This registration relates to the early detection of breast, cervical and colorectal cancer. These data, together with the associated pathology reports, are transferred to BCR in the form of a structured dataset. These data are subsequently treated and registered in the cyto-histopathology register.
BCR organises information sessions at regular intervals for the laboratory staff responsible for registering these data. During an info session, various topics may be covered, such as data processing of the received data, additional explanation of the feedback reports for laboratories, etc.
More information about the cyto-histopathology register can be found under ‘Screening’ and more information about the info sessions on registering these data is available through the professional platform.
